Clinuvel Pharmaceuticals Dividenden en inkoop
Dividend criteriumcontroles 0/6
Clinuvel Pharmaceuticals is een dividendbetalend bedrijf met een huidig rendement van 0.38%.
Belangrijke informatie
0.4%
Dividendrendement
0.1%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | 0.5% |
| Toekomstig dividendrendement | 0.9% |
| Dividendgroei | 24.4% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | AU$0.050 |
| Uitbetalingsratio | 7% |
Recente updates van dividend en inkoop
Recent updates
If EPS Growth Is Important To You, Clinuvel Pharmaceuticals (ASX:CUV) Presents An Opportunity
Aug 11
Calculating The Intrinsic Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Jun 27Is Now The Time To Put Clinuvel Pharmaceuticals (ASX:CUV) On Your Watchlist?
May 09Estimating The Intrinsic Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Mar 24An Intrinsic Calculation For Clinuvel Pharmaceuticals Limited (ASX:CUV) Suggests It's 41% Undervalued
Nov 18Increases to Clinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Compensation Might Cool off for now
Oct 20Is Clinuvel Pharmaceuticals Limited (ASX:CUV) Trading At A 21% Discount?
Jul 30Clinuvel Pharmaceuticals Limited (ASX:CUV) Shares Could Be 27% Below Their Intrinsic Value Estimate
Feb 27Does Clinuvel Pharmaceuticals (ASX:CUV) Deserve A Spot On Your Watchlist?
Dec 14This Is The Reason Why We Think Clinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Might Be Underpaid
Nov 03A Look At The Fair Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Sep 23Here's Why I Think Clinuvel Pharmaceuticals (ASX:CUV) Might Deserve Your Attention Today
Jul 23With EPS Growth And More, Clinuvel Pharmaceuticals (ASX:CUV) Is Interesting
Apr 10Have Insiders Sold Clinuvel Pharmaceuticals Limited (ASX:CUV) Shares Recently?
Mar 06Earnings Miss: Clinuvel Pharmaceuticals Limited Missed EPS By 41% And Analysts Are Revising Their Forecasts
Feb 27What Is The Ownership Structure Like For Clinuvel Pharmaceuticals Limited (ASX:CUV)?
Feb 20Clinuvel Pharmaceuticals (ASX:CUV) Shareholders Have Enjoyed A Whopping 648% Share Price Gain
Feb 01Estimating The Fair Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Jan 14We Wouldn't Rely On Clinuvel Pharmaceuticals's (ASX:CUV) Statutory Earnings As A Guide
Dec 28
Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Dec 10What You Need To Know About Clinuvel Pharmaceuticals Limited's (ASX:CUV) Investor Composition
Nov 21Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: CUV betaalt geen noemenswaardig dividend uit voor de Australian markt. Daarom is het niet nodig om te controleren of de betalingen stabiel zijn.
Groeiend dividend: CUV betaalt geen noemenswaardig dividend uit voor de Australian markt. Daarom is het niet nodig om te controleren of de betalingen toenemen.
Dividendrendement versus markt
| Clinuvel Pharmaceuticals Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (CUV) | 0.4% |
| Markt onderkant 25% (AU) | 2.6% |
| Markt Top 25% (AU) | 6.0% |
| Gemiddelde industrie (Biotechs) | 2.3% |
| Analist prognose (CUV) (tot 3 jaar) | 0.9% |
Opmerkelijk dividend: Het dividend van CUV ( 0.38% ) is niet noemenswaardig vergeleken met de onderste 25% van de dividendbetalers op de Australian markt ( 2.63% ).
Hoog dividend: Het dividend CUV ( 0.38% ) is laag vergeleken met de top 25% van dividendbetalers in de Australian markt ( 6.01% ).
Winstuitkering aan aandeelhouders
Verdiendekking: CUV betaalt geen noemenswaardig dividend uit voor de Australian markt.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: CUV betaalt geen noemenswaardig dividend uit voor de Australian markt.